ChinaBio® Today Articles

Welcome to the ChinaBio® Today store. As a service to our readers, we offer access to individual articles for only $5.00 (USD) each.  Of course, a subscription is only $20/mo, so you may prefer to subscribe.  If so, click on Subscribe in the menu.

Browse


All Products

Viewing 1606 - 1620 of 5660 products
CANbridge Forms Gene Therapy Research Program with UMass for Rare Diseases
$5.00
Available
MabPlex Raises $71 Million for Biopharmaceutical CDMO Services
$5.00
Available
Everest Medicines of Shanghai Closes $310 Million C Round for In-licensed Drugs
$5.00
Available
Nanjing Legend Bio Completes $424 Million NASDAQ IPO; Shares Rise 60%
$5.00
Available
Beijing Jiushi Shenkang Closes $14 Million Funding for Neurovascular Products
$5.00
Available
BeiGene Approved to Launch BTK Inhibitor in China for Two Cancer Indications
$5.00
Available
Deep Informatics++ Closes $14 Million Series B for AI-based Pathology Products
$5.00
Available
Innovent Reports Trial Data from PD-1 Drug in Three Separate Indications
$5.00
Available
Jiangsu Atom Raises $30 Million to Support Global Trial of Gout Drug
$5.00
Available
Harbour Biomed Approved for China Phase II/III Trials of Graves' Ophthalmopathy Treatment
$5.00
Available
Nanjing Legend Biotech Plans to Raise $350 Million in US IPO at $2.6 Billion Valuation
$5.00
Available
Genor Bio Closes $160 Million B Round to Develop Ten Biologic Clinical Candidates
$5.00
Available
Jacobio, a Beijing Pharma, Out-Licenses Two SHP2 Candidates to AbbVie
$5.00
Available
Kintor Pharma Stages $240 Million Hong Kong IPO for Androgen Receptor Drugs
$5.00
Available
MGI Tech, a BGI Subsidiary, Raises $1 Billion to Make Gene Sequencing Machines
$5.00
Available